Managing hypoglycaemia risk in non-diabetic CKD patients
Why GLP-1s rarely cause low blood sugar in non-diabetics, and what to watch for if you have kidney failure.
Written by Professor Mohammed Mahdi Althaf
Overview
GLP-1 medications are glucose-dependent, meaning they only stimulate insulin when sugar is high. However, in advanced CKD, medication clearance is slower, and risk profiles change.
This article is general information and is not individual medical advice. Treatment decisions are made at a face-to-face consultation.
More in Side effects, safety and contraindications
Book your first consultation
Booking done on Professor Althaf's clinic page and clicking here will take you there